Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot SMART Design for Pathological Gamblers
This study is currently recruiting participants.
Study NCT00685724   Information provided by National Institute on Drug Abuse (NIDA)
First Received: May 23, 2008   No Changes Posted

May 23, 2008
May 23, 2008
January 2008
July 2010   (final data collection date for primary outcome measure)
self and collateral indices of gambling and gambling related problems [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
 
 
 
A Pilot SMART Design for Pathological Gamblers
A Pilot SMART Design for Pathological Gamblers

Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.

 
Phase II
Interventional
Treatment, Randomized, Open Label, Factorial Assignment
Pathological Gambling
  • Behavioral: Motivational Enhancement Therapy (MET)
  • Behavioral: Cognitive-Behavioral Therapy (CBT)
  • Experimental: Following 2 sessions of MET intervention received by all patients, patients in Condition 1 receive no further intervention.
  • Experimental: Patients in Condition 2 will receive 8 sessions of the CBT (Cognitive Behavioral Therapy) intervention.
  • Experimental: Patients in Condition 3 will receive 8 sessions of CBT plus aftercare treatment.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
July 2010
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age > 18 years old, DSM-IV criteria for pathological gambling
  • >2 gambling episodes in past 60 days
  • spent >$100 wagering in the past 60 days
  • willingness to accept random assignment after the brief intervention.

Exclusion Criteria:

  • Reading level below 5th grade
  • uncontrolled psychiatric conditions (e.g., active suicidal intention, psychosis, bipolar disorder)
Both
18 Years and older
No
Contact: Ellen Ciesielski 860.679.4556 ciesielski@psychiatry.uchc.edu
United States
 
NCT00685724
Nancy Petry, Ph.D., UConn Health Center
07-259, P50-DA09241
National Institute on Drug Abuse (NIDA)
 
Principal Investigator: Nancy M Petry, Ph.D. University of Connecticut Health Center
National Institute on Drug Abuse (NIDA)
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP